# Peter Villax

> Peter Villax is a seed investor at Bionova Capital backing Medical and Hospital. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Bionova Capital](https://shizune.co/investors/profile/hovione-capital)
- Total investments: 2
- Last investment: May 2022
- Lead investor: 0%
- Last updated: Aug 2026

Peter Villax is a seed investor at Bionova Capital focused on Medical and Hospital. Peter Villax is Bionova Capital’s Chairman. He joined Hovione in 1982 as a computer programmer and led Hovione’s computerization, then switched to pharmaceutical development in 1990 and soon became interested in in pulmonary delivery. His disposable dry-powder inhaler TwinCaps, licensed to Daiichi Sankyo for the delivery of Influenza drug Inavir®,continues to be the only commercial device of its kind in the world, and has helped Daiichi Sankyo become the market leader in influenza products in Japan. He acquired significant experience as an inventor of devices, as a patentholder and as licensor of technology patents. In 2013 together with Miguel Calado, he was involved in a 7-figure royalty monetization deal with a US-based financial company, under which Hovione sold the future income streams earned under a license agreement. Peter Villax is also active in civic duties, as president of the Family Business Association in Portugal, a member of three University faculty boards (Pharmacy in U. Coimbra, Medicine in U.Lisbon and the Institute of Chemical and Biological Technology in U.Nova) as well as of other organizations. He is a lecturer and a frequent speaker at scientific, academic and business conferences and an ocasional participant in TV programmes.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Hospital | 1 | 50% |
| Health Care | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Spain | 1 | 50% |
| Portugal | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Delox | Delox is a spin-off of the Faculty of Sciences of the University of Lisbon (FCUL), whose goals consist in the design, development, and production of a vast portfolio of automatic biodecontamination robots. Target applications include the sterilization of medical devices in hospitals, health centers and field hospitals (for humanitarian missions,catastrophe situations, and war zones); room biodecontamination in hospitals, pharma, food industry and space; and laboratory equipment biodecontamination. | $785.5K | Seed | May 18, 2022 |  |
| Vaxdyn | Vaxdyn develops vaccines using novel technology. They offers pathogen vaccines for preventing antibiotics-resistant infections. Their customers' inquiries are addressed through phone, email, and online applications. | $355.5K | Seed | Mar 08, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [Arquimea Ingeniera](https://shizune.co/investors/profile/arquimea-ingeniera) — VC Fund, 1 deal together
- [Caixa Capital](https://shizune.co/investors/profile/caixa-capital-2) — VC Fund, 1 deal together
- [Fundacion Botin](https://shizune.co/investors/profile/fundacion-botin) — VC Fund, 1 deal together
- [Kiilto Ventures](https://shizune.co/investors/profile/kiilto-ventures) — VC Fund, 1 deal together
- [Reig Jofre](https://shizune.co/investors/profile/reig-jofre) — VC Fund, 1 deal together

## About Bionova Capital

VC Fund · Lisbon, Portugal

Bionova Capital, previously known as Hovione Capital, is a healthcare-focused venture capital firm, investing in early-stage life science companies. It was founded in 2015 by the shareholders of Hovione, one of the largest pharmaceutical companies in Portugal, with manufacturing and research operations in USA, Ireland, China and Portugal. BionovaCapital invests in groundbreaking therapeutics, medtech and digital health startups across Europe.

2 contacts available at Bionova Capital.

| Name | Title | Profile |
| --- | --- | --- |
| João Ventura Fernandes | Venture Partner | https://shizune.co/investors/profile/jo%C3%A3o-ventura-fernandes |
| Peter Villax | Chairman | https://shizune.co/investors/profile/peter-villax |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Peter Villax invest in?

Peter Villax invests primarily in Medical, Hospital and Health Care startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Peter Villax last invest?

The most recent investment recorded for Peter Villax closed in May 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co